Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer

被引:89
|
作者
Kestin, LL [1 ]
Martinez, AA [1 ]
Stromberg, JS [1 ]
Edmundson, GK [1 ]
Gustafson, GS [1 ]
Brabbins, DS [1 ]
Chen, PY [1 ]
Vicini, FA [1 ]
机构
[1] William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA
关键词
D O I
10.1200/JCO.2000.18.15.2869
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We performed a matched-pair analysis to compare our institution's experience in treating locally advanced prostate cancer with external-beam radiation therapy (EBRT) alone to EBRT in combination with conformal interstitial high-dose-rate (HDR) brachytherapy boosts (EBRT + HDR), Materials and Methods: From 1991 to 1998, 161 patients with locally advanced prostate cancer were prospectively treated with EBRT + HDR at William Beaumont Hospital, Royal Oak, Michigan. Patients with any of the following characteristics were eligible for study entry: pretreatment prostate-specific antigen (PSA) level of greater than or equal to 10.0 ng/mL, Gleason score greater than or equal to 7, or clinical stage T2b to T3c, Pelvic EBRT (46.0 Gy) was supplemented with three (1991 through 1995) or two (1995 through 1998) ultrasound-guided transperineal interstitial iridium-192 HDR implants, The brachytherapy dose was escalated from 5.50 to 10.50 Gy per implant, Each of the 161 EBRT + HDR patients wets randomly matched with a unique EBRT-alone patient. Patients were matched according to PSA level, Gleason score, T stage, and follow-up duration. The median PSA fallow-up was 2.5 years for both EBRT + HDR and EBRT alone. Results: EBRT + HDR patients demonstrated significantly lower PSA nadir levels (median, 0.4 ng/mL) compared with those receiving EBRT alone (median, 1.1 ng/mL), The 5-year biochemical control rater for EBRT + HDR versus EBRT-alone patients were 67% versus 44%, respectively (P < .001), On multivariate analyses, pretreatment PSA, Gleason score, T stage, and the use of EBRT alone were significantly associated with biochemical failure, Those patients in both treatment groups who experienced biochemical failure had a lower 5-year cause-specific survival rate than patients who were biochemically controlled (84% v 100%; P < .001). Conclusion: Locally advanced prostate cancer patients treated with EBRT + HDR demonstrate improved biochemical control compared with those who are treated with conventional doses of EBRT alone, J Clin Oncol 18:2869-2880, (C) 2000 by American Society of Clinical Oncology.
引用
收藏
页码:2869 / 2880
页数:12
相关论文
共 50 条
  • [21] High dose rate afterloading brachytherapy boost and conventional external beam radiation therapy for initial and local advanced prostate cancer
    Pellizzon, ACA
    Salvajoli, J
    Fogaroli, R
    Novaes, PES
    Maia, MA
    Ferrigno, R
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 296 - 296
  • [22] High dose rate afterloading brachytherapy boost and conventional external beam radiation therapy for initial and local advanced prostate cancer
    Pellizzon, AC
    Salvajoli, JV
    Fogaroli, R
    Novaes, PE
    Maia, M
    Ferigno, P
    RADIOLOGY, 2001, 221 : 282 - 283
  • [23] Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone
    Fang, Fu-Min
    Wang, Yu-Ming
    Wang, Chong-Jong
    Huang, Hsuan-Ying
    Chiang, Po-Hui
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (07) : 474 - 479
  • [24] Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results
    Hoskin, Peter J.
    Rojas, Ana M.
    Ostler, Peter J.
    Bryant, Linda
    Lowe, Gerry J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 154 : 214 - 219
  • [25] BRACHYTHERAPY OR CONFORMAL EXTERNAL RADIOTHERAPY FOR PROSTATE CANCER: A SINGLE-INSTITUTION MATCHED-PAIR ANALYSIS
    Pickles, Tom
    Keyes, Mira
    Morris, W. James
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (01): : 43 - 49
  • [26] Randomized trial comparing iridium plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate
    Sathya, J
    Davis, IR
    Julien, JA
    Guo, Q
    Daya, D
    Dayes, IS
    Lukka, HR
    Levin, M
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S5 - S5
  • [28] Intraoperative versus external beam boost for breast cancer: A matched-pair analysis.
    Sperk, Elena
    Astor, Daniela
    Welzel, Grit
    Gerhardt, Axel
    Suetterlin, Marc
    Wenz, Frederik K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer
    Tamihardja, Joerg
    Lawrenz, Ingulf
    Lutyj, Paul
    Weick, Stefan
    Guckenberger, Matthias
    Polat, Buelent
    Flentje, Michael
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (08) : 735 - 743
  • [30] Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer
    Jörg Tamihardja
    Ingulf Lawrenz
    Paul Lutyj
    Stefan Weick
    Matthias Guckenberger
    Bülent Polat
    Michael Flentje
    Strahlentherapie und Onkologie, 2022, 198 : 735 - 743